Paper3958496
Specificity and neutralizing capacity of antibodies elicited by a synthetic peptide of scorpion toxin.
Bahraoui EM and 4 others. J Immunol, 1986. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Specificity and neutralizing capacity of antibodies elicited by a synthetic peptide of scorpion toxin. Papers, record 3958496. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3958496
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Specificity and neutralizing capacity of antibodies elicited by a synthetic peptide of scorpion toxin.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Specificity | Major topic |
| Antitoxins | Major topic |
| Immunoglobulin G | Major topic |
| Peptide Fragments | Major topic |
| Scorpion Venoms | Major topic |
| Animals | |
| Antibody Affinity | |
| Binding, Competitive | |
| Carrier Proteins | |
| Chromatography, Gel | |
| Immune Sera | |
| Rabbits | |
| Serum Albumin, Bovine |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38868522 | Evaluation of the immunoprotective power of a multiple antigenic peptide against Aah II toxin of Androctonus australis hector scorpion. | Vaccine X | 2024 | https://conductscience.org/library/papers/38868522 | PubMed |
| 32550593 | Synthetic peptides to produce antivenoms against the Cys-rich toxins of arachnids. | Toxicon X | 2020 | https://conductscience.org/library/papers/32550593 | PubMed |
| 30678116 | Serotherapy against Voltage-Gated Sodium Channel-Targeting αToxins from Androctonus Scorpion Venom. | Toxins (Basel) | 2019 | https://conductscience.org/library/papers/30678116 | PubMed |
| 30400220 | Innovative Immunization Strategies for Antivenom Development. | Toxins (Basel) | 2018 | https://conductscience.org/library/papers/30400220 | PubMed |
| 27455327 | Biotechnological Trends in Spider and Scorpion Antivenom Development. | Toxins (Basel) | 2016 | https://conductscience.org/library/papers/27455327 | PubMed |
| 27003615 | Probing the Impact of Local Structural Dynamics of Conformational Epitopes on Antibody Recognition. | Biochemistry | 2016 | https://conductscience.org/library/papers/27003615 | PubMed |
| 22371498 | Structural insights into antibody sequestering and neutralizing of Na+ channel α-type modulator from old world scorpion venom. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22371498 | PubMed |
| 14651724 | Evaluation of two carrier protein-angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man. | Br J Clin Pharmacol | 2003 | https://conductscience.org/library/papers/14651724 | PubMed |
| 8302824 | Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8302824 | PubMed |
| 2446325 | Influence of protein flexibility and peptide conformation on reactivity of monoclonal anti-peptide antibodies with a protein alpha-helix. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/2446325 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3958496
GET https://conductscience.org/api/papers/v1/3958496/authors